ICDs and CRT-Ds programmed with Merlin Programmer Software Version 17.2.2 rev. 0 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 St 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2014-01-28
  • 사례 출판 날짜
    2014-01-28
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: st. jude medical icds and crt-ds programmed with merlin programmer software version 17.2.2 rev. 0 the australia therapeutic goods administration (tga) posted a medical device safety alert concerning implantable cardioverter-defibrillators (icds) and cardiac resynchronization therapy defibrillators (crt-ds) programmed with merlin programmer software version 17.2.2 rev. 0, manufactured by st. jude medical. according to the manufacturer’s information, the affected models include current vr, current accel vr rf, current dr, current accel dr rf, promote, promote accel rf, promote quadra, analyst accel vr rf, analyst accel dr rf, fortify st vr, fortify st dr, fortify assura vr, fortify assura dr, ellipse vr, ellipse dr, unify, unify quadra, unify assura crt-d, quadra assura crt-d, and quadra assura mp crt-d. when using the 17.2.2 software and any parameter that is programmed as part of a single vf detection zone configuration, the sinus redetection value will be inappropriately set to zero milliseconds. as a result, any intrinsic activity following the first shock will be considered a “sinus rate” and the device will diagnose “return to sinus”. therefore, if the arrhythmia was not terminated by the initial high voltage therapy, the ongoing arrhythmia would be considered a new episode causing the next high voltage therapy to also be delivered at the first programmed energy level. the manufacturer advises users of the followings: review st jude medical icd/crt-d patient records for patients with affected devices implanted or seen in clinic starting in september 2013 and programmed to a single vf detection zone with the 17.2.2 software. for patients identified during this review, users should schedule an immediate follow-up visit. for patient devices programmed as described above with 17.2.2 software, st. jude medical will arrange installation of a new software version 17.2.3 to correct this issue. if a patient is seen before the 17.2.3 software is installed, then program the device to a two or three zone configuration, even if one of the zones is strictly a monitor zone. this will resolve the issue when using a programmer with 17.2.2 software. according to the local supplier, products with affected software version 17.2.2 were not distributed in hong kong. for details, please refer to tga websitehttp://www.Tga.Gov.Au/sara/arn-detail.Aspx?k=rc-2014-rn-00034-1 if you are in possession of the product, please contact your supplier for necessary actions. posted on 28 january 2014.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: St. Jude Medical ICDs and CRT-Ds programmed with Merlin Programmer
  • Manufacturer
    St

Manufacturer

St
  • 제조사 모회사 (2017)
  • 제조사 의견
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    DH